Navigation Links
Intelligent Design Book Delivers Blow to Darwin
Date:11/17/2009

CRACKS AMAZON.COM BEST SELLER LIST IN SCIENCE

Signature in the Cell makes 2009 list of top ten best selling science books

SEATTLE, Nov. 17 /PRNewswire-USNewswire/ -- Despite Darwinists' attempts to suppress the debate over evolution, a new book about the controversial theory of intelligent design made Amazon.com's list of the year's Top 10 bestselling books in science, just as the world marks 150 years since Charles Darwin published his own theory in his landmark book On the Origin of Species.

Signature in the Cell: DNA and the Evidence for Intelligent Design (HarperOne) by Dr. Stephen C. Meyer is entering its fifth printing in as many months, and continues to sell strongly both online and in stores, according to the publisher. According to Amazon.com, books on its 2009 list of best sellers are "[r]anked according to customer orders through October. Only books published for the first time in 2009 are eligible."

"Darwin is mistakenly thought to have killed the design argument in science," said Robert Crowther, director of communications at Discovery Institute's Center for Science and Culture, which is the intelligent design research program directed by Dr. Meyer. "Now, here's a book about the science of intelligent design that shows how the design argument is being revived with powerful new arguments relevant to our culture."

By using the same method of reasoning that Darwin himself used, Dr. Meyer explains how intelligent design can be formulated as a rigorous scientific argument. In Signature in the Cell Dr. Meyer shows that the digital code imbedded in DNA points powerfully to a designing intelligence and helps unravel a mystery that Darwin did not address: how did the very first life begin?

www.discovery.org/csc

www.amazon.com

SOURCE Discovery Institute


'/>"/>
SOURCE Discovery Institute
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Intelligent Design Film to Premiere at Sam Noble Oklahoma Museum of Natural History Sept. 29
2. UK scientists developing intelligent harvesting robot to save farms up to 100,000 a year
3. Quest PharmaTech Announces Strategic Alliance with IntelligentNano to Develop Nanotechnology-Based Next Generation SL052
4. Elekta Brings Intelligent Ways to Manage Motion During Cancer Treatment to ESTRO
5. Daval International Awarded Orphan Drug Designation for Motor Neurone Disease Treatment
6. AMT Receives EMEA Orphan Drug Designation for Duchenne Muscular Dystrophy
7. CryoLife Receives Humanitarian Use Device Designation for SynerGraft(R) Processed Human Aortic Heart Valves
8. Northeast Indiana Regional Partnership to Participate in 2009 Orthopedic Design & Technology Conference & Exhibition
9. Oncolytics Biotech(R) Inc. Reaches Special Protocol Assessment Agreement with the FDA on Design of Phase 3 Trial for REOLYSIN(R) in Head and Neck Cancers
10. TCT 2009 to Feature vProtect(TM) Luminal Shield, a Novel Treatment Designed for Soft Coronary Lesions from Prescient Medical
11. AEterna Zentaris Partner, Keryx Biopharmaceuticals, Receives Orphan-Drug Designation for Perifosine (KRX-0401) for the Treatment of Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... Jan. 18, 2017 The global biotechnology ... 92.9 billion by 2025, according to a new ... has been adaptive of the function of outsourcing ... 2002. Among the services outsourced, clinical trial management ... Johnson & Johnson was the first pharmaceutical company ...
(Date:1/19/2017)... -- Acupath Laboratories, Inc., a leading provider of sub-specialized ... Committee that will guide the company,s vision and strategy ... , a 15-year veteran of the anatomic pathology industry, ... Chief Sales Officer .  Prior to joining Acupath ... leadership roles at several leading lab industry organizations including, ...
(Date:1/18/2017)... Portland, OR (PRWEB) , ... January 18, 2017 ... ... modules that provide essential device-to-computer interconnect using USB or PCI Express, announced the ... Altera Cyclone V E FPGA into a compact business-card sized form factor suitable ...
(Date:1/18/2017)... , Jan. 18, 2017   Boston Biomedical ... compounds designed to target cancer stemness pathways, will feature ... compound, napabucasin, at the 2017 ASCO Gastrointestinal Cancers Symposium, ... . Napabucasin is an orally-administered ... targeting STAT3. i Cancer stem cells (CSCs) possess ...
Breaking Biology Technology:
(Date:12/22/2016)... 20, 2016  As part of its longstanding mission to ... genetics company, recently released its latest children,s book, titled ... focuses on the topics of inheritance and variation of traits ... taught in elementary school classrooms in the US. ... illustrator Ariana Killoran , whose previous book with 23andMe, ...
(Date:12/20/2016)... RALEIGH, N.C. and GENEVA, Dec, 20, 2016 ... performance biometric data sensor technology, and STMicroelectronics ... across the spectrum of electronics applications, announced today ... scalable development kit for biometric wearables that includes ... integrated with Valencell,s Benchmark™ biometric sensor ...
(Date:12/16/2016)... DUBLIN , Dec 16, 2016 Research ... Access System Market - Global Forecast to 2021" report to ... ... projected to grow at a CAGR of 14.06% from 2016 to ... 2016, and is projected to reach 854.8 Million by 2021. The ...
Breaking Biology News(10 mins):